UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`
`ADMISSION OF ERIC J. LOBENFELD, ESQ., UNDER 37 C.F.R. § 42.10(c)
`
`ASAHI GLASS CO., LTD.
`Patent Owners.
`
`Petitioners,
`
`V.
`
`SANTEN PHARMACEUTICAL CO., LTD. AND
`
`Case IPR2017—01434
`
`US. Patent No. 5,886,035
`
`PATENT OWNERS’ AMENDED MOTION FOR PRO HAC VICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`
`ADMISSION OF ERIC J. LOBENFELD, ESQ., UNDER 37 C.F.R. § 42.10(c)
`
`ASAHI GLASS CO., LTD.
`Patent Owners.
`
`Petitioners,
`
`V.
`
`SANTEN PHARMACEUTICAL CO., LTD. AND
`
`Case IPR2017—01434
`
`US. Patent No. 5,886,035
`
`PATENT OWNERS’ AMENDED MOTION FOR PRO HAC VICE
`
`
`
`Relief Requested
`
`Pursuant to 37 C.F.R. § 42.10(c), Patent Owners Santen Pharmaceutical Co.,
`
`Ltd. (“Santen”) and Asahi Glass Co., Ltd. (“Asahi”) (together, “Patent Owners”)
`
`respectfully request that the Patent Trial and Appeal Board (“the Board”) recognize
`
`Eric J. Lobenfeld, Esq., as counsel pro hac vice on behalf of Patent Owners during
`
`this proceeding.
`
`On June 12, 2017, Patent Owners submitted their Motion for Pro Hac Vice
`
`Admission of Eric J. Lobenfeld, Esq., Under 37 C.F.R. §42.10(c). Patent Owners
`
`hereby submit the present Amended Motion for Pro Hac Vice Admission of Eric.
`
`J. Lobenfeld, Esq., in order to correct an inadvertent error in the prior submission.
`
`Specifically, Patent Owners and Mr. Lobenfeld neglected to identify that, in the
`
`where the lead counsel is a registered practitioner, a motion to
`
`last three (3) years, Mr. Lobenfeld applied for and appeared pro hac vice before the
`
`United States Patent and Trademark Office in IPR2015-01310.
`
`In an Inter Partes Review (“IPR”), the Board has discretion under 37 C.F.R.
`
`§ 42.10(c) to recognize counselpro hac vice. 37 C.F.R. § 42.10(c) provides that:
`
`The Board may recognize counsel pro hac vice during a
`
`proceeding upon a showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner and to
`
`any other conditions as the Board may impose. For example,
`
`
`
`appear pro hac vice by counsel who is not a registered
`
`practitioner may be granted upon showing that counsel is an
`
`experienced litigating attorney and has an established
`
`familiarity with the subject matter at issue in the proceeding.
`
`In support of this motion, a declaration of Eric J. Lobenfeld is submitted
`
`hac vice admission as set forth in IPR2013-00639, Paper 7, dated October 15,
`
`2013.
`
`This motion is being filed no sooner than twenty-one (21) days after service
`
`ofthe petition.
`
`11.
`
`Statement of Facts
`
`herewith (Exhibit 1) showing that Mr. Lobenfeld satisfies the requirements for pro
`
`the United States Supreme Court. See Lobenfeld Declaration, 112.
`
`Based on the following facts, and supported by the Declaration of Eric J.
`
`Lobenfeld (Exhibit 1) submitted herewith, Patent Owners have established good
`
`cause for the Board to recognize Mr. Lobenfeld pro hac vice in this matter:
`
`1.
`
`2.
`
`Lead counsel, Ms. Arlene L. Chow, is a registered practitioner.
`
`Mr. Lobenfeld is a Partner with the law firm Hogan Lovells U.S. LLP.
`
`See Lobenfeld Declaration, 111.
`
`3.
`
`Mr. Lobenfeld is a member in good standing of the State Bar of New
`
`York and numerous United States District Courts, Circuit Courts of Appeals, and
`
`
`
`4.
`
`Mr. Lobenfeld has been a litigating attorney for more than forty (40)
`
`years. See Lobenfeld Declaration, 113. He has been litigating patents for the
`
`past twenty-five (25) years and has been lead counsel on dozens of patent cases.
`
`1d.
`
`5.
`
`Mr. Lobenfeld has never been suspended from, disbarred from, or
`
`denied admission to practice before any court or administrative body. See
`
`Lobenfeld Declaration, 1114-5.
`
`6.
`
`No sanctions or contempt citations have ever been imposed against
`
`Mr. Lobenfeld by any court or administrative body. See Lobenfeld Declaration,
`
`01310. See Lobenfeld Declaration, 19. Prior to that, Mr. Lobenfeld appeared pro
`
`Practice Guide and the Board’s Rules of Practice for Trials set forth in part 42 of
`
`116.
`
`7.
`
`Mr. Lobenfeld has read and will comply with the Office Patent Trial
`
`the 37 C.F.R. See Lobenfeld Declaration, 117.
`
`8.
`
`Mr. Lobenfeld understands that he will be subject to the USPTO
`
`Rules of Professional Conduct set forth in 37 C.F.R. § 11.101 et seq. and
`
`disciplinaryjurisdiction under 37 C.F.R. § 1 l.l9(a). See Lobenfeld Declaration,
`
`"8.
`
`9.
`
`In the past three (3) years, Mr. Lobenfeld has applied for and appeared
`
`pro hac vice before the United States Patent and Trademark Office in IPR2015-
`
`
`
`hac vice in the following proceedings: IPR2014-00651, IPR2014-00652,
`
`lPR2014-00653, IPR2014-00654, IPR2014-00655, and IPR2014-00656. Id.
`
`10. Mr. Lobenfeld is Patent Owners’ trial counsel in the concurrent
`
`litigations Santen Pharmaceutical Co., Ltd., Asahi Glass Co., Ltd. and Oak
`
`Pharmaceuticals, Inc. v. Micro Labs Limited and Micro Labs USA Inc, Case No.
`
`16—cv—00353, and Santen Pharmaceutical Co., Ltd, Asahi Glass Co., Ltd. and Oak
`
`proceeding; he is Patent Owners’ trial counsel in their concurrent district court
`
`Declaration, for the past 25 years, Mr. Lobenfeld has been litigating patent cases
`
`Pharmaceuticals, Inc. v. Sandoz Inc, Case No. 16-cv-00354, in the United States
`
`District Court for the District of Delaware. Those cases involve the same patent
`
`and the same prior art submitted by Petitioners in the Petition of this proceeding.
`
`See Lobenfeld Declaration, 1110.
`
`III. Good Cause Exists for Pro Hac Vice Admission
`
`In accordance with 37 C.F.R. § 42.lO(c), the Board may recognize counsel
`
`pro hac vice during a proceeding upon showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner and to any other condition
`
`the Board may impose. 37 C.F.R. § 42.10(c). Patent Owners’ lead counsel, Ms.
`
`Arlene L. Chow, is a registered practitioner. Furthermore, as supported by his
`
`and has been lead counsel on dozens of patent cases. Mr. Lobenfeld also has
`
`developed an established familiarity with the subject matter at issue in this
`
`
`
`litigation against the Petitioners (Santen Pharmaceutical Co., Ltd, Asahi Glass
`
`Co., Ltd. and Oak Pharmaceuticals, Inc. v. Micro Labs Limited and Micro Labs
`
`USA Inc, Case No. l6-cv-00353 (D. Del.)) and district court litigation against
`
`Sandoz Inc. (Santen Pharmaceutical Co., Ltd, Asahi Glass Co, Ltd. and Oak
`
`Pharmaceuticals, Inc. v. Sandoz Inc, Case No. 16-cv-00354 (D. Del.)). This
`
`proceeding involves the same patent (i. e., US. Patent No. 5,886,035) at issue in
`
`those concurrent litigations.
`
`As trial counsel for Patent Owners, Mr. Lobenfeld has been actively
`
`involved in all aspects of the concurrent district court litigations. Given his
`
`knowledge of the subject matter at issue in this proceeding and the concurrent
`
`Admission is accompanied by a Declaration of Eric J. Lobenfeld, Esq. (Exhibit 1).
`
`district court litigations, Patent Owners would benefit from Mr. Lobenfeld’s
`
`expertise and involvement in this proceeding.
`
`[11. Conclusion
`
`Patent Owners respectfully submit that, in light of the foregoing, there is
`
`good cause for the Board to recognize Mr. Lobenfeld as counsel pro hac vice for
`
`Patent Owners during this proceeding. This Amended Motion for Pro Hac Vice
`
`
`
`Dated: June 14, 2017
`
`New York, New York 10022
`
`Telephone: (212) 918-3000
`Fax: (212)918-3100
`
`Counselfor Patent Owners
`Santen Pharmaceutical C0,, Ltd.
`
`Respectfully submitted,
`
`/Arlene L. Chow /
`
`Arlene L. Chow
`
`Registration No. 47,489
`Ernest Yakob
`
`Registration No. 45,893
`Hogan Lovells US LLP
`875 Third Avenue
`
`and Asahi Glass C0., Ltd.
`
`
`
`EXHIBIT 1
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`
`Petitioners,
`
`V.
`
`ADMISSION OF ERIC J. LOBENFELD, ESQ., UNDER 37 C.F.R. § 42.10(c)
`
`DECLARATION OF ERIC. J. LOBENFELD, ESQ., IN SUPPORT OF
`PATENT OWNERS’ AMENDED MOTION FOR PRO HAC VICE
`
`SANTEN PHARMACEUTICAL CO., LTD. AND
`
`ASAHI GLASS CO., LTD.
`Patent Owners.
`
`Case IPR2017-01434
`
`US. Patent No. 5,886,035
`
`
`
`I, Eric J. Lobenfeld, being duly sworn and upon oath, hereby attest to the
`
`following:
`
`1.
`
`I am an attorney—at-law and a Partner with the law firm Hogan Lovells
`
`U.S. LLP.
`
`have been litigating patents for the past twenty-five (25) years and have been lead
`
`I understand that I will be subject to the USPTO Rules of Professional
`
`2.
`
`I am a member in good standing of the State Bar of New York and
`
`numerous United States District Courts, Circuit Courts of Appeals, and the United
`
`States Supreme Court.
`
`3.
`
`I have been a litigating attorney for more than forty (40) years.
`
`I
`
`counsel on dozens of patent cases.
`
`4.
`
`l have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never been denied admission to practice before any court or
`
`administrative body.
`
`6.
`
`No sanctions or contempt citations have ever been imposed against
`
`me by any court or administrative body.
`
`7.
`
`l have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of the 37
`
`CPR.
`
`
`
`37 C.F.R. § 11.19(a).
`
`9.
`
`In the past three (3) years, I have applied for and appeared pro hac
`
`vice before the United States Patent and Trademark Office in IPR2015-01310.
`
`Prior to that, I have appeared pro hac vice in the following proceedings:
`
`lPR2014-
`
`00651; IPR2014-00652; lPR2014-00653; lPR2014-00654; lPR2014-00655; and
`
`lPR2014—00656.
`
`Conduct set forth in 37 C.F.R. § 1 1.101 et seq. and disciplinaryjurisdiction under
`
`under section 1001 of Title 18 of the United States Code and that such willful false
`
`10.
`
`l have an established familiarity with the subject matter at issue in this
`
`proceeding.
`
`I am Patent Owners’ trial counsel in the concurrent litigations Santen
`
`Pharmaceutical Co., Ltd, Asahi Glass Co., Ltd. and Oak Pharmaceuticals, Inc. v.
`
`Micro Labs Limited and Micro Labs USA Inc, Case No. 16-cv-00353, and Santen
`
`Pharmaceutical Co., Ltd, Asahi Glass Co., Ltd. and Oak Pharmaceuticals, Inc. v.
`
`Sandoz Inc, Case No. 16—cv—00354 (D. Del. 2016), in the United States District
`
`Court for the District of Delaware. Those cases involve the same patent and the
`
`same prior art submitted by Petitioners in the Petition of this proceeding.
`
`I hereby declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements are made with the knowledge that Willfill false
`
`statements and the like so made are punishable by fine or imprisonment, or both
`
`
`
`0 J. Lobenfeld
`
`‘ N LOVELLS US L .
`
`875 T ird Avenue
`
`statements may jeopardize the validity of US. Patent No. 5,886,035.
`
`Executed on June 14, 2017, in New York, New York.
`
`ork, New York 10022
`Tel phone: (212) 918—3000
`Fax: (212) 918-3100
`
`Email: eric.lobenfeld@hoganlovells.com
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR § 42.6(e), the undersigned certifies that on June 14,
`
`2017, a complete and entire copy of this Patent Owners’ Amended Motion for Pro
`
`Hac Vice Admission of Eric J. Lobenfeld, Esq. was provided via electronic mail to
`
`the attorneys of record for Petitioners:
`
`Cedric C.Y. Tan, Reg. No. 56,082
`PILLSBURY WINTHROP
`
`SHAW PITTMAN LLP
`
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Tel.: (202) 663-8000
`Fax.: (202) 663—8007
`Email: cedric.tan@pillsburylawcom
`
`Sean M. Weinman, Reg. No. 69,515
`PILLSBURY WINTHROP
`
`SHAW PITTMAN LLP
`
`Registration No. 47,489
`
`1650 Tysons Boulevard, 14th Floor
`McLean, VA 22102
`Tel.: (703) 770-7511
`Fax.: (703) 770-4856
`Email: sean.weinmanngillsburylaw.com
`
`MicroLabsl PRgeri l lsburylawcom
`
`/Arlene L. Chow /
`
`Arlene L. Chow
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
